Interaction between theophylline and oestrogen in the rat uterus

Area of Science:

• Reproductive biology
• Pharmacology

Background:

• Oestrogen-17 beta (estradiol) plays a key role in uterine physiology.
• Theophylline is a methylxanthine drug with known anti-inflammatory properties.

Purpose of the Study:

• To investigate the synergistic effects of theophylline and oestrogen-17 beta on uterine tissue.
• To elucidate the mechanisms underlying theophylline's influence on oestrogen-induced uterine responses.

Main Methods:

• Administration of theophylline and varying doses of oestrogen-17 beta to animal models.
• Measurement of uterine RNA and protein content.
• Assessment of uterine oedema and eosinophil counts.
• In vitro analysis of oestrogen binding by uterine eosinophils.

Main Results:

• Theophylline potentiated oestrogen-induced increases in uterine RNA and protein content.
• Combined administration led to enhanced uterine oedema.
• Theophylline reduced blood and uterine eosinophil counts.
• In vitro studies showed increased oestrogen binding by eosinophils in the presence of theophylline.

Conclusions:

• Theophylline can augment oestrogen's effects on uterine tissue, potentially through modulation of eosinophil activity.
• The observed increase in oestrogen binding by eosinophils may explain the enhanced uterine oedema in vivo.